Interferon-Oftalmo (Drops) Instructions for Use

Marketing Authorization Holder

Lekko, CJS (Russia)

Manufactured By

Lekko, CJS (Russia)

Or

Pharmstandard-UfaVITA OJSC (Russia)

ATC Code

S01AD05 (Interferon)

Active Substances

Diphenhydramine (Rec.INN WHO registered)

Interferon alfa-2b (USAN adopted for use in the USA)

Dosage Form

Interferon-Oftalmo

Eye drops 10000 IU+1 mg/1 ml: bottle 5 ml or 10 ml

Dosage Form, Packaging, and Composition

Eye drops as a clear, colorless or slightly yellowish liquid.

Excipients: hypromellose (hydroxypropyl methylcellulose) – 3.5 mg, polidronium chloride – 0.025 mg, disodium edetate – 0.4 mg, boric acid – 3.1 mg, sodium acetate trihydrate – 7 mg, potassium chloride – 5 mg, purified water – up to 1 ml.

5 ml – polymer bottles (1) with a dropper cap – cardboard packs.
5 ml – polymer bottles (1) with a dropper attachment – cardboard packs.
10 ml – polymer bottles (1) with a dropper cap – cardboard packs.
10 ml – polymer bottles (1) with a dropper attachment – cardboard packs.
0.5 ml – single-use polyethylene dropper tubes (5) – foil film bags (2) – cardboard packs.

Clinical-Pharmacological Group

Antiviral drug for topical use in ophthalmology

Pharmacotherapeutic Group

Drugs used in ophthalmology; antimicrobials; antiviral drugs

Pharmacological Action

It has antiviral, anti-inflammatory, immunomodulatory, antimicrobial, local anesthetic, and regenerating action.

Indications

Conjunctivitis: adenoviral, enteroviral (hemorrhagic), herpetic; keratitis: adenoviral, herpetic (vesicular, punctate, dendritic, geographic; stromal, including with corneal ulceration); keratoconjunctivitis: adenoviral, herpetic; herpetic uveitis and keratouveitis (including with ulcerations).

ICD codes

Dosage Regimen

Use topically in the eye only.

In the acute phase of the disease, instill 1-2 drops into the conjunctival sac of the affected eye up to 6-8 times daily.

As the inflammatory process subsides, reduce the frequency of administration to 2-3 times per day.

Continue the course of treatment until the complete resolution of all clinical symptoms.

Do not allow the dropper tip to contact the eye, eyelids, or any other surfaces to prevent contamination of the solution.

For single-use dropper tubes: use the entire contents of one tube for one administration and then discard it.

If wearing contact lenses, remove them before instillation; you may reinsert them 15 minutes after administration.

If there is no clinical improvement within 3-5 days, discontinue use and consult an ophthalmologist.

Adverse Reactions

None noted.

Contraindications

Hypersensitivity to this combination.

Special Precautions

If there is no improvement within 5 days of treatment and if side effects occur, consultation with an ophthalmologist is necessary.

Storage Conditions

Store at 2°C (36°F) to 8°C (46°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.